Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial.

MLA

Jotte, Robert, et al. “Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial.” Journal of Thoracic Oncology, vol. 15, no. 8, Aug. 2020, pp. 1351–60. EBSCOhost, https://doi.org/10.1016/j.jtho.2020.03.028.

APA

Jotte, R., Cappuzzo, F., Vynnychenko, I., Stroyakovskiy, D., Rodríguez-Abreu, D., Hussein, M., Soo, R., Conter, H. J., Kozuki, T., Huang, K.-C., Graupner, V., Sun, S. W., Hoang, T., Jessop, H., McCleland, M., Ballinger, M., Sandler, A., & Socinski, M. A. (2020). Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial. Journal of Thoracic Oncology, 15(8), 1351–1360. https://doi.org/10.1016/j.jtho.2020.03.028

Chicago

Jotte, Robert, Federico Cappuzzo, Ihor Vynnychenko, Daniil Stroyakovskiy, Delvys Rodríguez-Abreu, Maen Hussein, Ross Soo, et al. 2020. “Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial.” Journal of Thoracic Oncology 15 (8): 1351–60. doi:10.1016/j.jtho.2020.03.028.